Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
measles + mumps + rubella + varicella virus vaccine live
- Development stage
- Approved
- Lead developer
- Merck
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
Measles + mumps + rubella + varicella virus vaccine live is a combination vaccine containing live attenuated viruses for the prevention of four diseases: measles (rubeola), mumps, rubella (German measles), and varicella (chickenpox). The mechanism of action involves stimulating the immune system to produce antibodies against these viruses by introducing weakened forms that do not cause disease in healthy individuals. This active immunization provides protection by enabling the body to mount a rapid immune response upon exposure to any of these pathogens. The primary indication is for routine childhood immunization and catch-up vaccination in susceptible individuals. The developer and main manufacturer is Merck & Co.[1][2][3][4][7]
- Brand names
- ProQuad
- Other names
- MMRVmeasles, mumps, rubella, and varicella virus vaccine liveMMRV vaccine
Beyond the preview
Go deeper on measles + mumps + rubella + varicella virus vaccine live.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on measles + mumps + rubella + varicella virus vaccine live.